A Study of the Use of Text Message Reminders to Take Palbociclib

N/AActive Not RecruitingNCT04216576

Memorial Sloan Kettering Cancer Center45 enrolled

Overview

The purpose of this study is to find out whether it is feasible (acceptable to participants) to use a smartphone app to send text message reminders to take palbociclib, and whether these reminders are effective at helping people remember to take palbociclib according to the treatment schedule.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

NONE

Enrollment

Conditions

Breast Cancer

Interventions

Paper Drug DiaryOTHER

Participants will receive and use a paper Drug Diary and a paper medication calendar.

OhMD APPOTHER

Participants will receive multiple text messages regarding administration over time on medication self-management over the course of 3 cycles of medication

Eligibility

Sex: FEMALEMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with a breast cancer diagnosis who are initiating therapy on palbociclib (Ibrance) * \>/= 18 years of age * Able to speak, read and write English * Willingness and ability to send and receive text messages with intervention app * Own a mobile telephone "smartphone" with text messaging capabilities. Only iPhone or Android operating systems support OhMD Application * Criteria applicable for both Control and Intervention groups * Flip-phones do not support OhMD Application and thus ineligible to participate * Initiation palbociclib (Ibrance) for the first time, either as monotherapy or in conjunction with other medication such as Lstrozole (Femara) or Fulvestrant (Faslodex) Exclusion Criteria: * History of taking palbociclib (Ibrance) * Patients whose caregivers coordinate their health care

Locations (7)

Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)

Basking Ridge, New Jersey, United States

Memorial Sloan Kettering Monmouth (Limited Protocol Activities)

Middletown, New Jersey, United States

Memorial Sloan Kettering Bergen (Limited Protocol Activities)

Montvale, New Jersey, United States

Outcomes

Primary Outcomes

Accuracy rate of medication self-administration

The effectiveness of a mobile technology intervention by calculating the proportion of the number of days that the participant accurately self-administers the medication divided by the number of days the medication should have been taken

Time frame: Up to 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.